AbCellera Biologics Inc. 4

Insider Michael R. Hayden indirectly donated 50,000 AbCellera Biologics Inc. common shares to charity via Genworks 2 Consulting, Inc. on 2026-08-11.

On August 11, 2026, insider Michael R. Hayden reported a disposition coded as transaction type "G" reflecting a charitable donation of 50,000 AbCellera Biologics Inc. common shares made by Genworks 2 Consulting, Inc., an entity whose shares are held with sole voting and investment power by his spouse. The transaction is reported as an indirect disposition, and the reporting person disclaims beneficial ownership except to the extent of any indirect pecuniary interest. Following this donation, the reported indirect holdings through this entity total 1,273,397 common shares, and an additional 118,245 common shares are indirectly held by his spouse. As this is a non-sale charitable transfer rather than an open-market sale or purchase, it is generally viewed as low in signaling value about the issuer’s fundamentals.

Filing Facts

CIK

1703057

Ticker

ABCL

Form

4

Source Type

fda

Accession

0001628280-26-056653

Alert Tier

4